Posttransplantation lymphoproliferative disorders

被引:63
作者
Andreome, P
Gramenzi, A
Lorenzini, S
Biselli, M
Cursaro, C
Pileri, S
Bernardi, M
机构
[1] Policlin S Orsola, Dipartimento Med Interna CardioAngiol & Epatol, I-40138 Bologna, Italy
[2] Policlin S Orsola, Ist Ematol & Oncol Med Le A Seragnoli, I-40138 Bologna, Italy
关键词
D O I
10.1001/archinte.163.17.1997
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Posttransplantation lymphoproliferative disorders include a wide spectrum of diseases ranging from hyperplastic-appearing lesions to frank non-Hodgkin lymphoma. More than 90% of these disorders are Epstein-Barr virus-associated lesions of B-cell origin that arise in the setting of pharmacologic immunosuppression after transplantation. With the increased use of organ transplantation and intensive immunosuppression, posttransplantation lymphoproliferative disorders are becoming more common. The prognosis is often poor, with most patients dying despite receiving treatment. The aim of this review is to report the most recent knowledge about the clinical features, diagnosis, prophylaxis, and treatment of posttransplantation lymphoproliferative disorders, which can be useful to physicians and health assistants dealing with these life-threatening, posttransplantation clinical entities in clinical practice.
引用
收藏
页码:1997 / 2004
页数:8
相关论文
共 77 条
[1]  
[Anonymous], 1996, Fields virology
[2]  
[Anonymous], 2001, Pathology and Genetics
[3]   EBV persistence in memory B cells in vivo [J].
Babcock, GJ ;
Decker, LL ;
Volk, M ;
Thorley-Lawson, DA .
IMMUNITY, 1998, 9 (03) :395-404
[4]  
Badley A D, 1996, Liver Transpl Surg, V2, P375, DOI 10.1002/lt.500020508
[5]   High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders [J].
Baldanti, F ;
Grossi, P ;
Furione, M ;
Simoncini, L ;
Sarasini, A ;
Comoli, P ;
Maccario, R ;
Fiocchi, R ;
Gerna, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :613-619
[6]   Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients [J].
Barker, JN ;
Martin, PL ;
Coad, JE ;
DeFor, T ;
Trigg, ME ;
Kurtzberg, J ;
Weisdorf, DJ ;
Wagner, JE .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (07) :395-399
[7]   Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines [J].
Beatty, PR ;
Krams, SM ;
Esquivel, CO ;
Martinez, OM .
TRANSPLANTATION, 1998, 65 (09) :1248-1255
[8]   Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: Prognostic factors and long-term outcome [J].
Benkerrou, M ;
Jais, JP ;
Leblond, V ;
Durandy, A ;
Sutton, L ;
Bordigoni, P ;
Garnier, JL ;
Le Bidois, J ;
Le Deist, F ;
Blanche, S ;
Fischer, A .
BLOOD, 1998, 92 (09) :3137-3147
[9]   Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation [J].
Birkeland, SA ;
Bendtzen, K ;
Moller, B ;
Hamilton-Dutoit, S ;
Andersen, HK .
TRANSPLANTATION, 1999, 67 (06) :876-881
[10]   Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: Use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol [J].
Birkeland, SA ;
Andersen, HK ;
Hamilton-Dutoit, SJ .
TRANSPLANTATION, 1999, 67 (09) :1209-1214